Search research articles
Contact Us
Filters
Showing results (1-10 of 226) with videos related to
Page
of 23
Sort By:
Chinese Clinical Oncology
|
February 21, 2020
On the cusp of a sea change in biliary tract cancer
Milind Javle
Current Oncology Reports
|
July 16, 2021
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
Gentry King, Milind Javle
Oncology (Williston Park, N.Y.)
|
July 2, 2011
Targeting the insulin growth factor pathway in gastrointestinal cancers
Talia Golan, Milind Javle
Journal of Gastrointestinal Oncology
|
October 18, 2016
Molecular profiling of biliary tract cancer: a target rich disease
Apurva Jain, Milind Javle
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development
Talia Golan, Milind Javle
Cancer Control : Journal of the Moffitt Cancer Center
|
October 5, 2017
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
Yun Shin Chun, Milind Javle
ACP Journal Club
|
July 5, 2007
Review: neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer
Milind Javle, Gary Y Yang
Journal of Hematology & Oncology
|
March 25, 2010
Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology
Milind Javle, Chung-Tsen Hsueh
The Lancet. Oncology
|
September 1, 2025
A GOLP rush in biliary tract cancer: early promise in the quest for curative surgery
Dan G Duda, Milind Javle
Journal of Hematology & Oncology
|
February 25, 2009
Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology
Milind Javle, Chung-Tsen Hsueh
Page
of 23
Search research articles
Search
Showing results (1-10 of 226) with videos related to
Sort By:
Page
of 23
Chinese Clinical Oncology
|
February 21, 2020
On the cusp of a sea change in biliary tract cancer
Milind Javle
Current Oncology Reports
|
July 16, 2021
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma
Gentry King, Milind Javle
Oncology (Williston Park, N.Y.)
|
July 2, 2011
Targeting the insulin growth factor pathway in gastrointestinal cancers
Talia Golan, Milind Javle
Journal of Gastrointestinal Oncology
|
October 18, 2016
Molecular profiling of biliary tract cancer: a target rich disease
Apurva Jain, Milind Javle
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development
Talia Golan, Milind Javle
Cancer Control : Journal of the Moffitt Cancer Center
|
October 5, 2017
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
Yun Shin Chun, Milind Javle
ACP Journal Club
|
July 5, 2007
Review: neoadjuvant chemoradiotherapy and chemotherapy improve survival in operable esophageal cancer
Milind Javle, Gary Y Yang
Journal of Hematology & Oncology
|
March 25, 2010
Recent advances in gastrointestinal oncology--updates and insights from the 2009 annual meeting of the American society of clinical oncology
Milind Javle, Chung-Tsen Hsueh
The Lancet. Oncology
|
September 1, 2025
A GOLP rush in biliary tract cancer: early promise in the quest for curative surgery
Dan G Duda, Milind Javle
Journal of Hematology & Oncology
|
February 25, 2009
Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology
Milind Javle, Chung-Tsen Hsueh
Page
of 23